Table 2.
Top 20 lncRNAs significantly associated to the prognosis of patients in the training set (N = 257).
| LncRNA | HR | CI95 | Cox p value |
|---|---|---|---|
| LINC01759 | 0.58 | 0.47–0.71 | 0.000001 |
| LINC00475 | 0.41 | 0.29–0.59 | 0.000001 |
| AC128689.1 | 1.44 | 1.24–1.66 | 0.000001 |
| UBXN10_AS1 | 0.64 | 0.54–0.77 | 0.000001 |
| BX322234.1 | 1.86 | 1.44–2.4 | 0.000002 |
| LINC00501 | 1.68 | 1.36–2.08 | 0.000002 |
| AC025154.2 | 0.75 | 0.67–0.85 | 0.000003 |
| AC009005.1 | 0.72 | 0.62–0.83 | 0.000005 |
| UNQ6494 | 0.4 | 0.27–0.6 | 0.000005 |
| AC007991.2 | 1.57 | 1.29–1.9 | 0.000005 |
| AC084866.1 | 0.78 | 0.7–0.87 | 0.000009 |
| LINC00954 | 1.62 | 1.31–2 | 0.000009 |
| AP003306.1 | 0.45 | 0.31–0.64 | 0.000010 |
| PAX8_AS1 | 1.59 | 1.29–1.95 | 0.000012 |
| AC104662.3 | 0.56 | 0.43–0.72 | 0.000013 |
| AL353593.3 | 1.76 | 1.36–2.28 | 0.000018 |
| AC011294.1 | 1.78 | 1.37–2.32 | 0.000020 |
| AC007032.1 | 2.9 | 1.78–4.75 | 0.000021 |
| AC068987.4 | 1.39 | 1.2–1.62 | 0.000022 |
| AC015849.5 | 1.65 | 1.31–2.08 | 0.000023 |